Is small-bowel bacterial overgrowth an underdiagnosed disorder in children with gastrointestinal symptoms?

Hilary F Jones1, Geoffrey P Davidson, Doug A Brooks

  • 1PERI Centre and Mechanisms in Cell Biology and Disease Research Group, Sansom Institute for Health Research, School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, Australia.

Insights

Small-bowel bacterial overgrowth (SBBO) is common in children with gastrointestinal issues. The lactulose breath hydrogen test found SBBO in 16% of children investigated for carbohydrate malabsorption.

Area of Science:

  • Pediatric Gastroenterology
  • Microbiology
  • Digestive Health

Background:

  • Small-bowel bacterial overgrowth (SBBO) is linked to chronic abdominal pain and irritable bowel syndrome in children.
  • Previous research suggests a connection between SBBO and gastrointestinal symptoms in pediatric populations.

Purpose of the Study:

  • To determine the prevalence of SBBO in children referred for carbohydrate malabsorption investigation.
  • To assess the utility of the lactulose breath hydrogen test in diagnosing SBBO in this cohort.

Main Methods:

  • Retrospective analysis of 287 children undergoing investigation for carbohydrate malabsorption.
  • Utilized the lactulose breath hydrogen test to identify small-bowel bacterial overgrowth.
  • Analyzed hydrogen-producing children (n=250) for SBBO indicators.

Main Results:

  • Small-bowel bacterial overgrowth (SBBO) was identified in 16% (39/250) of hydrogen-producing children.
  • The prevalence of SBBO suggests it may be more common than previously thought in children with these symptoms.
  • Carbohydrate malabsorption investigations revealed a significant occurrence of SBBO.

Conclusions:

  • Small-bowel bacterial overgrowth (SBBO) is a notable finding in children presenting with gastrointestinal symptoms and suspected carbohydrate malabsorption.
  • The lactulose breath hydrogen test is a valuable tool for identifying SBBO in pediatric patients.
  • Further research is warranted to understand the full impact and management of SBBO in children.

Related Concept Videos

Dysbiosis of the Gut Microbiota01:18

Dysbiosis of the Gut Microbiota

The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Irritable Bowel Syndrome01:23

Irritable Bowel Syndrome

DefinitionIrritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by recurrent combinations of abdominal pain, bloating, diarrhea, or constipation.Pathophysiology of irritable bowel syndromeIts pathophysiology is multifactorial, involving disturbances in motility, sensory processing, microbial balance, barrier integrity, and gut–brain communication. These mechanisms interact to produce symptoms that vary across IBS subtypes.Altered Motility PatternsDisordered...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...